Home > Rheumatology > EULAR 2022 > Best of The Posters > High prevalence of fibromyalgia in patients with inflammatory bowel disease

High prevalence of fibromyalgia in patients with inflammatory bowel disease

Presented By
Dr Laura Guida , Luigi Sacco University Hospital, Italy
Conference
EULAR 2022
Doi
https://doi.org/10.55788/d540f471
An Italian study including patients with inflammatory bowel disease (IBD) revealed that those also suffering from fibromyalgia have a significantly impaired quality-of-life. IBD patients with this comorbidity present particularly psychological manifestations like depression, anxiety, and stress, but also chronic fatigue and sleep disturbances.   Fibromyalgia, characterised by widespread pain, fatigue, sleep disturbances, and functional symptoms, has a worldwide prevalence of 2–3% [1]. However, a meta-analysis published previously showed that the prevalence of fibromyalgia in the general population is significantly lower than in populations with certain diseases and can be as high as 12.9% in patients with IBD [1]. Information on the prevalence and the impact of fibromyalgia in patients with IBD is limited. To address this knowledge gap, Dr Laura Guida (Luigi Sacco University Hospital, Italy) and her team performed a study on consecutive patients ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on